Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lysosomes | 5 | 2025 | 21 | 1.860 |
Why?
|
| Inflammasomes | 6 | 2022 | 40 | 1.710 |
Why?
|
| Endothelial Cells | 7 | 2024 | 47 | 1.700 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 6 | 2022 | 40 | 1.580 |
Why?
|
| Autophagy | 6 | 2025 | 30 | 1.460 |
Why?
|
| Myocytes, Smooth Muscle | 4 | 2025 | 18 | 1.200 |
Why?
|
| Mice, Inbred C57BL | 9 | 2024 | 184 | 1.190 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 3 | 2025 | 11 | 1.170 |
Why?
|
| Sphingomyelin Phosphodiesterase | 4 | 2025 | 13 | 1.100 |
Why?
|
| Signal Transduction | 5 | 2025 | 216 | 1.060 |
Why?
|
| Hypercholesterolemia | 2 | 2024 | 13 | 1.040 |
Why?
|
| Coronary Vessels | 4 | 2024 | 27 | 0.950 |
Why?
|
| Cells, Cultured | 9 | 2025 | 127 | 0.880 |
Why?
|
| Coronary Circulation | 1 | 2024 | 6 | 0.870 |
Why?
|
| Microcirculation | 1 | 2024 | 7 | 0.870 |
Why?
|
| Cell Differentiation | 1 | 2025 | 71 | 0.850 |
Why?
|
| Animals | 17 | 2025 | 1711 | 0.810 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 225 | 0.800 |
Why?
|
| Mice | 13 | 2025 | 685 | 0.780 |
Why?
|
| Tight Junctions | 3 | 2019 | 9 | 0.770 |
Why?
|
| Cathepsin B | 2 | 2019 | 7 | 0.740 |
Why?
|
| Nanospheres | 1 | 2021 | 1 | 0.680 |
Why?
|
| Hydrogen Peroxide | 1 | 2021 | 5 | 0.680 |
Why?
|
| Silicon Dioxide | 1 | 2021 | 19 | 0.670 |
Why?
|
| Copper | 1 | 2021 | 33 | 0.650 |
Why?
|
| Graphite | 1 | 2020 | 10 | 0.640 |
Why?
|
| Gold | 1 | 2020 | 49 | 0.620 |
Why?
|
| Simvastatin | 1 | 2020 | 5 | 0.620 |
Why?
|
| Muscle, Smooth, Vascular | 5 | 2025 | 23 | 0.610 |
Why?
|
| Nicotine | 1 | 2019 | 38 | 0.580 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 176 | 0.570 |
Why?
|
| HMGB1 Protein | 5 | 2020 | 15 | 0.480 |
Why?
|
| Cell Proliferation | 4 | 2025 | 115 | 0.420 |
Why?
|
| Cell Movement | 4 | 2025 | 61 | 0.420 |
Why?
|
| Mice, Knockout | 6 | 2025 | 140 | 0.380 |
Why?
|
| Reactive Oxygen Species | 3 | 2024 | 30 | 0.380 |
Why?
|
| Piperidines | 2 | 2025 | 15 | 0.370 |
Why?
|
| Atherosclerosis | 2 | 2025 | 16 | 0.360 |
Why?
|
| Male | 8 | 2024 | 2491 | 0.340 |
Why?
|
| Cell Survival | 2 | 2020 | 54 | 0.300 |
Why?
|
| Endothelium, Vascular | 2 | 2019 | 17 | 0.270 |
Why?
|
| Diet, High-Fat | 4 | 2024 | 34 | 0.260 |
Why?
|
| Calcineurin | 1 | 2025 | 11 | 0.220 |
Why?
|
| Ezetimibe | 1 | 2024 | 3 | 0.220 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2024 | 6 | 0.220 |
Why?
|
| Acid Ceramidase | 1 | 2024 | 6 | 0.220 |
Why?
|
| Liver Cirrhosis | 1 | 2024 | 7 | 0.220 |
Why?
|
| Anticholesteremic Agents | 1 | 2024 | 6 | 0.220 |
Why?
|
| Vascular Calcification | 1 | 2024 | 6 | 0.220 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2024 | 9 | 0.220 |
Why?
|
| Lipid Metabolism | 1 | 2024 | 13 | 0.220 |
Why?
|
| Homeostasis | 1 | 2024 | 29 | 0.220 |
Why?
|
| Liver | 1 | 2024 | 49 | 0.210 |
Why?
|
| Staphylococcus aureus | 2 | 2021 | 20 | 0.200 |
Why?
|
| Interleukin-1beta | 2 | 2022 | 17 | 0.200 |
Why?
|
| Neointima | 2 | 2022 | 8 | 0.200 |
Why?
|
| Benchmarking | 1 | 2023 | 12 | 0.190 |
Why?
|
| Microscopy | 1 | 2023 | 35 | 0.190 |
Why?
|
| Humans | 7 | 2025 | 4936 | 0.180 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2021 | 1 | 0.170 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2021 | 5 | 0.170 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2021 | 36 | 0.170 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2021 | 96 | 0.160 |
Why?
|
| Amines | 1 | 2020 | 6 | 0.160 |
Why?
|
| Antigens, CD | 1 | 2020 | 6 | 0.160 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2020 | 7 | 0.160 |
Why?
|
| Cadherins | 1 | 2020 | 11 | 0.160 |
Why?
|
| Bacteria | 1 | 2020 | 47 | 0.150 |
Why?
|
| Cell Membrane Permeability | 1 | 2019 | 11 | 0.150 |
Why?
|
| Oxidative Stress | 1 | 2020 | 58 | 0.150 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 21 | 0.150 |
Why?
|
| Escherichia coli | 1 | 2021 | 111 | 0.150 |
Why?
|
| Sequestosome-1 Protein | 1 | 2018 | 4 | 0.140 |
Why?
|
| Amitriptyline | 1 | 2018 | 3 | 0.140 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2018 | 4 | 0.140 |
Why?
|
| Neovascularization, Physiologic | 1 | 2018 | 17 | 0.140 |
Why?
|
| Sphingosine | 1 | 2017 | 1 | 0.130 |
Why?
|
| Cystic Fibrosis | 1 | 2017 | 6 | 0.130 |
Why?
|
| Neutrophils | 1 | 2017 | 15 | 0.130 |
Why?
|
| Pseudomonas Infections | 1 | 2017 | 18 | 0.130 |
Why?
|
| Lung | 1 | 2017 | 35 | 0.130 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2017 | 34 | 0.130 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2016 | 9 | 0.120 |
Why?
|
| Hyperglycemia | 1 | 2016 | 10 | 0.120 |
Why?
|
| Dyneins | 1 | 2016 | 2 | 0.120 |
Why?
|
| Phagosomes | 1 | 2016 | 2 | 0.120 |
Why?
|
| Intercellular Junctions | 1 | 2015 | 4 | 0.110 |
Why?
|
| Adipokines | 1 | 2015 | 5 | 0.110 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 73 | 0.060 |
Why?
|
| Permeability | 2 | 2016 | 14 | 0.060 |
Why?
|
| Cell Line | 2 | 2016 | 84 | 0.060 |
Why?
|
| Osteogenesis | 1 | 2024 | 3 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2024 | 13 | 0.050 |
Why?
|
| Macrophages | 1 | 2025 | 26 | 0.050 |
Why?
|
| NLR Proteins | 1 | 2022 | 2 | 0.050 |
Why?
|
| Pyrin Domain | 1 | 2022 | 2 | 0.050 |
Why?
|
| Caspases | 1 | 2022 | 2 | 0.050 |
Why?
|
| Ceramides | 1 | 2022 | 4 | 0.050 |
Why?
|
| Superoxides | 1 | 2022 | 5 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2023 | 68 | 0.050 |
Why?
|
| Neurons | 1 | 2023 | 109 | 0.040 |
Why?
|
| Algorithms | 1 | 2023 | 241 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 9 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 18 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2018 | 4 | 0.040 |
Why?
|
| Myofibroblasts | 1 | 2018 | 6 | 0.040 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 4 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 6 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 14 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2018 | 16 | 0.040 |
Why?
|
| Phenotype | 1 | 2018 | 67 | 0.030 |
Why?
|
| Staphylococcal Infections | 1 | 2017 | 7 | 0.030 |
Why?
|
| Palmitates | 1 | 2016 | 2 | 0.030 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2016 | 3 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2016 | 3 | 0.030 |
Why?
|
| Caspase 1 | 1 | 2016 | 11 | 0.030 |
Why?
|
| Streptozocin | 1 | 2016 | 6 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2016 | 15 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 23 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 35 | 0.030 |
Why?
|
| Myocardium | 1 | 2016 | 34 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 24 | 0.030 |
Why?
|
| Tight Junction Proteins | 1 | 2015 | 4 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2015 | 11 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 8 | 0.030 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2015 | 4 | 0.030 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2015 | 5 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 23 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 49 | 0.030 |
Why?
|